Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 836 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 476.91 USD | -2.22% | -5.56% | -9.93% | +12.58% | 11.02 B USD | ||
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.89 USD | -0.56% | -6.20% | -13.98% | -0.90% | 10.63 B USD | ||
| 865 |  IBRX ImmunityBio, Inc. - Common Stock | 9.91 USD | +1.64% | +5.20% | +21.45% | +294.82% | 10.50 B USD | ||
| 892 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.75 USD | +1.01% | +4.55% | +1.76% | +98.61% | 10.02 B USD | ||
| 909 |  KRYS Krystal Biotech, Inc. - Common Stock | 327.30 USD | +0.84% | +0.17% | -6.18% | +74.91% | 9.69 B USD | ||
| 910 |  PCVX Vaxcyte, Inc. - Common Stock | 65.02 USD | -2.90% | +14.49% | +8.38% | +53.71% | 9.68 B USD | ||
| 941 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 109.30 USD | +0.88% | -1.74% | -5.24% | +84.94% | 9.09 B USD | ||
| 943 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 139.91 USD | -0.72% | -0.77% | -4.20% | +86.22% | 9.05 B USD | ||
| 955 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 170.08 USD | -1.67% | -6.36% | -18.22% | +30.63% | 8.91 B USD | ||
| 971 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.01 USD | +1.46% | -6.68% | -16.55% | +6.73% | 8.62 B USD | ||
| 973 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 60.74 USD | -1.20% | -6.05% | -28.25% | +55.35% | 8.58 B USD | ||
| 997 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.34 USD | +0.74% | -1.53% | -3.98% | +48.99% | 8.16 B USD | ||
| 1049 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 263.55 USD | -5.20% | -9.16% | -25.30% | +388.24% | 7.36 B USD | ||
| 1058 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 43.30 USD | -1.95% | -1.97% | -23.04% | -39.96% | 7.20 B USD | ||
| 1068 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 79.90 USD | -1.18% | -12.35% | -9.28% | +234.17% | 7.05 B USD | ||
| 1075 |  ABVX Abivax SA - American Depositary Shares | 89.05 USD | +2.34% | -7.07% | -24.66% | +2.23% | 6.99 B USD | ||
| 1145 |  IMVT Immunovant, Inc. - Common Stock | 30.26 USD | -5.56% | -11.26% | -22.63% | +57.52% | 6.25 B USD | ||
| 1151 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.64 USD | +1.35% | -5.61% | -10.63% | -18.74% | 6.17 B USD | ||
| 1167 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 13.31 USD | +3.02% | -7.95% | +53.70% | +488.94% | 6.03 B USD | ||
| 1172 |  BLTE Belite Bio Inc - American Depositary Shares | 152.52 USD | -2.28% | -6.72% | -20.18% | +95.21% | 6.00 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |